Docetaxel, Cisplatin and Fluorouracil in Treating Patients With Previously Untreated Stage II-IV Nasal Cavity and Paranasal Sinus Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Docetaxel
Related studies linked through entity extraction aliases.
Individualized Therapy Based of Tumoral mRNA Levels of ERCC1, RRM1 and BRCA1 in Advanced Non-Small-Cell Lung Cancer
- Status
- TERMINATED
- Phase
- PHASE2
Docetaxel/Epirubicin/Bevacizumab as First Line Therapy for Metastatic HER2 Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
PTC299 for Treatment of Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Phase I Study of Docetaxel and Temsirolimus in Resistant Solid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Phase III Study of Docetaxel + Ramucirumab or Placebo in Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
Effect of Ketoconazole Inhibition of CYP3A on Urinary Excretion of Docetaxel
- Status
- COMPLETED
- Phase
- PHASE2
The Effect of Docetaxel or Gemcitabine-based Chemotherapy in East Asian and Caucasian Patients
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel Plus Oxaliplatin as Therapy in Patients With Pancreatic Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Docetaxel in Node Positive Adjuvant Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3
A Study to Determine the Activity of Caelyx With Trastuzumab and Docetaxel in the Treatment of Metastatic Breast Cancer (Study P03679)
- Status
- COMPLETED
- Phase
- PHASE2
Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Docetaxel/Pemetrexed as 1st Line Treatment in Patients With Non Small Cell Lung Cancer (NSCLC)
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Docetaxel With or Without Vandetanib in Treating Patients With Metastatic Stomach Cancer or Gastroesophageal Junction Cancer
- Status
- TERMINATED
- Phase
- PHASE2
A Study of the Efficacy and Safety of Trastuzumab Emtansine (Trastuzumab-MCC-DM1) vs. Trastuzumab (Herceptin®) and Docetaxel (Taxotere®) in Patients With Metastatic HER2-positive Breast Cancer Who Have Not Received Prior Chemotherapy for Metastatic Disease
- Status
- COMPLETED
- Phase
- PHASE2
Phase 2 Trial Of CP-751,871 And Docetaxel In Advanced Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
The Effect of Preoperative Docetaxel, Cisplatin and Capecitabine on Serum RUNX3 Hypermethylation Status in Patients With Gastric and Lower Oesophagus Adenocarcinoma
- Status
- UNKNOWN
- Phase
- PHASE2
Validate Gene Expression and Proteomic Signatures Predictive of Treatment for Response for Breast Cancer Patient
- Status
- UNKNOWN
- Phase
- PHASE2
Postoperative Radiation Therapy, Hormonal Therapy and Concurrent Docetaxel for High Risk Pathologic Prostate Cancer
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Chemotherapy and Lapatinib or Trastuzumab in Treating Women With HER2/Neu-Positive Metastatic Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE3